Given the fact that the R5 virus plays pivotal roles in the early stages of infection and during sexual transmission, CCR5 has been considered an ideal drug target since its discovery as the primary coreceptor for HIV-1 entry in 1996 (5, 6). Here, CCR5 is linked to infection.